
EU Sets Withdrawal Dates For Manorapid Express GEL
The EU has adopted the cancellation of Manorapid express GEL's Union authorisation at its holder's request. Supply must stop from 6 June 2027 and stock use from 6 December 2027.
Foresight
2 min readAI-drafted, expert reviewed

The European Commission has adopted the cancellation of the Union authorisation for Manorapid express GEL at the authorisation holder's request. Implementing Regulation (EU) 2026/2526, published on 16 November 2026, sets separate deadlines for supply and use of existing stocks.
The measure concerns authorisation EU-0027675-0000, held by Lysoform Dr. Hans Rosemann GmbH. It enters into force on 6 December 2026.
Supply And Use Have Different Cut-Offs
Article 3 requires Manorapid express GEL to stop being made available on the market from 6 June 2027. Existing stocks must no longer be used from 6 December 2027.
The regulation therefore provides a transition between cancellation of the authorisation and the final supply and use deadlines. Publication does not impose an immediate stop on all existing sales or use.
Holder Cited Commercial Reasons
The regulation records that Lysoform requested cancellation on 23 July 2026. In its detailed explanation submitted on 15 September, the company said it had decided to discontinue production for commercial reasons.
The European Chemicals Agency forwarded the reasoned request to the Commission the following day. The new regulation cancels the authorisation in response to that request.
Earlier Union Authorisation Repealed
The regulation's historical account identifies Implementing Regulation (EU) 2023/1106, adopted on 6 June 2023, as the act granting the Union authorisation. It identifies propan-1-ol and propan-2-ol as the product's active substances.
Article 2 of the new measure repeals that earlier authorisation regulation. The cancellation concerns this named product and authorisation; it does not establish a general prohibition on those two alcohols.
Topics
Questions about this change
When must suppliers stop making Manorapid express GEL available on the EU market?
Under Regulation (EU) 2026/2526, Manorapid express GEL must no longer be made available on the market from 6 June 2027. Existing stocks must no longer be used from 6 December 2027. The cancellation regulation enters into force on 6 December 2026.
Why is the EU cancelling the Union authorisation for Manorapid express GEL?
The regulation says the holder, Lysoform Dr. Hans Rosemann GmbH, requested cancellation and explained that it would stop production for commercial reasons. The measure concerns authorisation EU-0027675-0000 for Manorapid express GEL, rather than a general prohibition on propan-1-ol or propan-2-ol.
Find out what this means for your products
Foresight follows changes like this one and shows where they reach your substances, products and markets.
Join 3,500+ professionals staying ahead
Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.
Read by professionals at

